Ledger.Open graph →

SEC Form D · Amendment · filed December 23, 2021

STAQ Pharma, Inc

Offering

$60.0M

Sold

$30.3M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

DENVER, CO

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Mark M. Spiecker · Denver, COExec · Director Chet M. Kaczor · Denver, CODirector Jeffrey L. Hval · Denver, COExec · Director Dan M. Seff · Denver, CODirector Joseph W. Bagan · Denver, COExec · Director Jerrod M. Milton · Denver, CODirector Steven M. Summer · Denver, CODirector Abram M. Gordon · Denver, CODirector Scott M. Hawig · Denver, CODirector Vanessa Peters · Fort Worth, TXExec · Director Christopher Haqq · Boston, MADirector Carol Ashe · Boston, MAExec · Director Amar U. Shah · Chicago, ILExec · Director Annette Matthies · Boston, MADirector Daniel Geffken · Boston, MADirector Robert Ruffolo · Boston, MADirector Stephen Luongo · Chicago, ILExec · Director Sheldon L. Trubatch · Chevy Chase, MDExec · Director Maximillian Amster · Tampa, FLExec · Director Everest Management, LLC · HUNTERSVILLE, NCDirector Karl J. Sanchack · Cranberry Township, PADirector Michael J. Lutzky · Takoma Park, PADirector Anthony Tamer · Miami, FLDirector Abram M. Gordon · Denver, CODirector Scott M. Hawig · Denver, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗